Biodexa Pharmaceuticals Enters into Non-binding Letter of Intent for Proposed…
<!-- Name:DistributionId Value:1000810748 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Biopharmaceutical
Biopharmaceutical Excipients Market Size Worth USD 2.24 Billion by 2030 at 5.70% CAGR…
<!-- Name:DistributionId Value:8832994 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Biopharmaceutical CMO Market to grow by USD 51.5 billion by 2032 | North America to…
<!-- Name:DistributionId Value:8824765 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Compass Therapeutics to Participate in the Stifel 2023 Virtual Targeted Oncology Days
<!-- Name:DistributionId Value:8810770 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Curia Collaborates with Corning to Advance Biopharmaceutical Continuous-Flow…
<!-- Name:DistributionId Value:8794440 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to…
<!-- Name:DistributionId Value:8790775 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Cytovance Biologics and Phenotypeca Collaborate to Enhance Saccharomyces cerevisiae…
<!-- Name:DistributionId Value:8786348 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
BiondVax’s Innovative Inhaled COVID-19 Therapy Virtually Eliminated SARS-COV-2 Virus…
Hamsters infected with SARS-COV-2 and then treated with BiondVax’s inhaled anti-COVID-19 nanosized antibodies (NanoAbs) had over 30-times lower lung viral titer on average compared to those…
Affimed Announces Approval of Clinical Trial Application in France for a Phase 1…
AFM28 monotherapy receives authorization of a Clinical Trial Application (CTA) for the phase 1 study by the French National Agency for the Safety of Medicines and Health Products…
Dr. Vince Clinical Research Strengthens Investigator Team with the Addition of George…
Overland Park, KS., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Dr. Vince Clinical Research (DVCR) announced the addition of highly experienced investigator George J. Atiee, M.D. to the medical…